Gold nanoparticles detect PSA for breast cancer

Prostate-specific antigen (PSA) has long been the best biomarker available for early detection of prostate cancer, despite problems with over-diagnoses and false positives. As it turns out, the PSA blood test is also a potential biomarker for breast cancer, but levels are so small in women that it would take an ultrasensitive test to measure them. Taiwanese researcher Chien Chou and colleagues have found a way to make a test sensitive enough. They've built a fiber-optic biosensor using gold nanoparticles and PSA antibodies to detect and report PSA levels using a fluorescent signal. The researchers say that it's able to detect elevated PSA levels in breast cancer cases, although they also say that it avoids false positives at the same rate as those found in prostate cancer PSA tests. Story | Abstract

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.